Skip to main content
. 2021 Apr 30;9:667435. doi: 10.3389/fcell.2021.667435

FIGURE 2.

FIGURE 2

PTEN is indispensable for MLN4924 to inhibit PI3K/Akt signaling pathway activity. (A) Immunoblot of WCL from MCF-7 cells and BT-549 (PTEN-null) cells with MLN4924 treatment (1 μM) for 12 h. (B) Immunoblot of WCL from shNC/Control or shPTEN/sgPTEN MCF-7 cells. The cells were treated with 1 μM MLN4924 for 12 h. (C,D) Quantitative mRNA level analysis of p27kip1 and p15INK4b in shNC and shPTEN MCF-7 cells. MLN4924 was used at indicated dose (1 μM; 12 h). The quantifications of indicated protein contents were analyzed. *P < 0.05, **P < 0.01, ***P < 0.001.